ATE519493T1 - Blockierendes peptid für die sekretion von entzündungszellen - Google Patents
Blockierendes peptid für die sekretion von entzündungszellenInfo
- Publication number
- ATE519493T1 ATE519493T1 AT02756467T AT02756467T ATE519493T1 AT E519493 T1 ATE519493 T1 AT E519493T1 AT 02756467 T AT02756467 T AT 02756467T AT 02756467 T AT02756467 T AT 02756467T AT E519493 T1 ATE519493 T1 AT E519493T1
- Authority
- AT
- Austria
- Prior art keywords
- secretion
- present
- inflammatory cell
- cell secretion
- blocking peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30093301P | 2001-06-26 | 2001-06-26 | |
PCT/US2002/022270 WO2003000027A2 (en) | 2001-06-26 | 2002-06-26 | Blocking peptide for inflammatory cell secretion |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE519493T1 true ATE519493T1 (de) | 2011-08-15 |
Family
ID=23161217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02756467T ATE519493T1 (de) | 2001-06-26 | 2002-06-26 | Blockierendes peptid für die sekretion von entzündungszellen |
Country Status (11)
Country | Link |
---|---|
US (2) | US20030013652A1 (de) |
EP (1) | EP1411967B1 (de) |
JP (1) | JP4610891B2 (de) |
AT (1) | ATE519493T1 (de) |
AU (1) | AU2002322475B2 (de) |
CA (1) | CA2452123A1 (de) |
DK (1) | DK1411967T3 (de) |
ES (1) | ES2369760T3 (de) |
HK (1) | HK1065702A1 (de) |
PT (1) | PT1411967E (de) |
WO (1) | WO2003000027A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8501911B2 (en) | 1999-02-24 | 2013-08-06 | Biomarck Pharmaceuticals, Ltd | Methods of reducing inflammation and mucus hypersecretion |
US7544772B2 (en) * | 2001-06-26 | 2009-06-09 | Biomarck Pharmaceuticals, Ltd. | Methods for regulating inflammatory mediators and peptides useful therein |
KR101445859B1 (ko) | 2005-01-20 | 2014-11-04 | 바이오마크 파마슈티칼스 리미티드 | 뮤신 과분비 억제제 및 그의 이용방법 |
WO2007056618A1 (en) | 2005-11-10 | 2007-05-18 | Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College | Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
PT2053915E (pt) * | 2006-07-26 | 2014-08-25 | Biomarck Pharmaceuticals Ltd | Peptídeos para atenuar a libertação de mediadores inflamatórios |
KR20130135820A (ko) | 2010-06-16 | 2013-12-11 | 엠베라 뉴로 테라퓨틱스 인코포레이티드 | 중독,정신 장애 및 신경퇴행성 질환 치료용 조성물 및 방법 |
JP6449849B2 (ja) | 2013-04-05 | 2019-01-09 | バイオマーク・ファーマシューティカルズ・リミテッド | 転移のインヒビター |
ES2952744T3 (es) | 2016-12-15 | 2023-11-03 | Nestle Sa | Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía |
US11179377B2 (en) | 2017-03-10 | 2021-11-23 | Embera Neurotherapeutics, Inc. | Pharmaceutical compositions and uses thereof |
AU2020298130A1 (en) * | 2019-06-17 | 2022-01-20 | Biomarck Pharmaceuticals Ltd. | Peptides and methods of use thereof in treating uveitis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292498A (en) * | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
CA2102142A1 (en) * | 1993-03-30 | 1994-10-01 | Andrew J. Ghio | Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
ES2230078T3 (es) * | 1999-02-24 | 2005-05-01 | North Carolina State University | Procedimientos y composiciones para alternar la secrecion de mucus. |
US6506779B1 (en) * | 1999-12-03 | 2003-01-14 | Pfizer Inc. | Acetylene derivatives as anti-inflammatory/analgesic agents |
ITTO20030856A1 (it) * | 2003-10-31 | 2005-05-01 | Skf Ab | Attuatore lineare a vite a ricircolo di sfere con un dispositivo di sbloccaggio di sicurezza. |
-
2002
- 2002-06-26 ES ES02756467T patent/ES2369760T3/es not_active Expired - Lifetime
- 2002-06-26 CA CA002452123A patent/CA2452123A1/en not_active Abandoned
- 2002-06-26 JP JP2003506483A patent/JP4610891B2/ja not_active Expired - Fee Related
- 2002-06-26 PT PT02756467T patent/PT1411967E/pt unknown
- 2002-06-26 EP EP02756467A patent/EP1411967B1/de not_active Expired - Lifetime
- 2002-06-26 DK DK02756467.3T patent/DK1411967T3/da active
- 2002-06-26 AU AU2002322475A patent/AU2002322475B2/en not_active Ceased
- 2002-06-26 AT AT02756467T patent/ATE519493T1/de active
- 2002-06-26 US US10/180,753 patent/US20030013652A1/en not_active Abandoned
- 2002-06-26 WO PCT/US2002/022270 patent/WO2003000027A2/en active Application Filing
-
2004
- 2004-03-17 US US10/802,644 patent/US20040180836A1/en not_active Abandoned
- 2004-10-28 HK HK04108491.3A patent/HK1065702A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK1411967T3 (da) | 2011-11-28 |
EP1411967A4 (de) | 2004-12-15 |
EP1411967A2 (de) | 2004-04-28 |
WO2003000027A3 (en) | 2003-05-08 |
EP1411967B1 (de) | 2011-08-10 |
PT1411967E (pt) | 2011-09-30 |
US20040180836A1 (en) | 2004-09-16 |
US20030013652A1 (en) | 2003-01-16 |
CA2452123A1 (en) | 2003-03-01 |
WO2003000027A2 (en) | 2003-01-03 |
HK1065702A1 (en) | 2005-03-04 |
AU2002322475B2 (en) | 2008-02-21 |
JP2005519850A (ja) | 2005-07-07 |
JP4610891B2 (ja) | 2011-01-12 |
ES2369760T3 (es) | 2011-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG170082A1 (en) | Methods for regulating inflammatory mediators and peptides useful therein | |
ATE519493T1 (de) | Blockierendes peptid für die sekretion von entzündungszellen | |
DK1015622T3 (da) | Praktisk sialylering in vitro af rekombinante glycoproteiner | |
ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
NZ515718A (en) | Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals | |
DE50109164D1 (de) | Therapeutische verwendung von extrakten aus sophora flavescens oder sophora subprostrata | |
WO2007075438A3 (en) | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor | |
DE502005009449D1 (de) | Metallreflektor und Verfahren zu dessen Herstellung | |
MX2009010547A (es) | Transferencia de punto de union de datos. | |
MXPA04002562A (es) | Combinacion de un pde-4 y nsaid. | |
IL150703A (en) | Selective electrochemical reduction of halogenated 4 - aminopicolinic acids | |
NO20044898L (no) | Nye etonogestrel estere | |
BR0016632A (pt) | Métodos e composições para a fabricação de lentes oftálmicas | |
TW200715814A (en) | Mobile communication device with silent conversation capability | |
NO20040604L (no) | Trisykliske imidazolpyridiner | |
DE502007000372D1 (de) | Schaumstoffsysteme, Kits und deren Verwendung | |
DE60209359D1 (de) | Lösungsmittelverklebungsverfahren | |
HUP0402165A2 (hu) | Nem neurotoxikus plazminogén aktiváló faktorok a szélhűdés kezelésére | |
DE60214676D1 (de) | Hochaffine antagonisten der elr-cxc chemokine | |
TW200741132A (en) | Luminescent element | |
IL158278A0 (en) | Chitosan and hydroxy carboxylic acid based porous and non-porous matrices | |
WO2003046139A3 (en) | CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE | |
BR0208892A (pt) | Ligação de diferentes protocolos de sinalização utilizando redes de comunicação | |
ATE168817T1 (de) | Leiterplattenrelais mit einpressanschlüssen | |
MY142798A (en) | Methods for preventing glyconoylation of proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1411967 Country of ref document: EP |